Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

Fig. 1

Relative changes (∆%) correlations between treatment efficacy outcomes improvement and PROMs changes (A: MIDAS, HIT-6, MSQT, BAI, BDI-II, MIG-SCOG; B: MSQT, MSQRFR, MSQRFP, MSQEF). Pie charts represent the strength of the correlation (rs) between pairwise ∆ and color the direction of this relationship (blue: positive, red: negative). Blank cells refer to non-statistically significantly correlation between pairwise ∆. Abbreviations MHD: monthly headache days; MMD: monthly migraine days; INT: headache pain intensity; AMD: days of acute medication intake; AMP: acute medication burden (pills/month); MIDAS: migraine disability assessment; HIT-6: headache impact test; MSQT: migraine-specific quality of life questionnaire (total score); MSQ-RFR: MSQ role-function restrictive; MSQ-RFP: MSQ role-function preventive; MSQ-EF: MSQ emotional function; BAI: Beck anxiety inventory; BDI-II: Beck depression inventory-second edition; MIG-SCOG: migraine attacks-subjective cognitive impairment scale.

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us